Broadly neutralizing antibodies such as 2F5 are directed against the membrane-proximal external region (MPER) of HIV-1 GP41 and recognize well-defined linear core sequences. These epitopes can be engrafted onto protein scaffolds to serve as immunogens with high structural fidelity. Although antibodies that bind to this core GP41 epitope can be elicited, they lack neutralizing activity. To understand this paradox, we used biophysical methods to investigate the binding of human 2F5 to the MPER in a membrane environment, where it resides in vivo. Recognition is stepwise, through a paratope more extensive than core binding site contacts alone, and dynamic rearrangement through an apparent scoop-like movement of heavy chain complementaritydetermining region 3 (CDRH3) is essential for MPER extraction from the viral membrane. Core-epitope recognition on the virus requires the induction of conformational changes in both the MPER and the paratope. Hence, target neutralization through this lipid-embedded viral segment places stringent requirements on the plasticity of the antibody combining site.
A protective vaccine against HIV-1 requires the stimulation of a robust immune response to elicit broadly neutralizing antibodies (BNAbs) 1 . BNAbs are essential to prevent viral pathology, generally by inhibiting entry of the retrovirus into host cells, thereby blocking viral replication as well as proviral integration into the human genome. Integration establishes latent reservoirs of disease 2 . The trimeric envelope protein, consisting of three protomers of GP120 noncovalently attached to GP41, is the only viral protein that is exposed on the virion surface. Entry of HIV-1 into human T lymphocytes is mediated first by attachment of its envelope GP120 subunit to the cellular receptor (CD4), followed by binding to the co-receptor (CCR5 or CXCR4) 3 . These interactions foster structural rearrangement of the membraneanchored HIV-1 envelope GP41 subunit, subsequently leading to viral fusion with the host cell 4, 5 . Therefore, antibody-mediated protection against HIV-1 must target accessible, functionally relevant and conserved spike epitopes.
The development of effective vaccines capable of eliciting BNAbs to HIV-1 has been extremely challenging. The failure to create an effective vaccine to control the global HIV-1 pandemic is a consequence of the extensive mechanisms exploited by the virus to escape protective humoral immunity [6] [7] [8] . Genetic sequence variability resulting from the error-prone HIV-1 reverse transcriptase has led the virus to evolve into many subtypes, and multiple quasispecies circulate at any one time in an infected individual. In most people infected with HIV-1, antibody-neutralizing activities are strain specific 6 . However, a few chronically infected subjects develop antibodies that are capable of neutralizing diverse viral strains 9 . Monoclonal antibodies (mAbs) that are broadly neutralizing have been isolated from these individuals and characterized in an effort to define potential targets for HIV-1 immunogen design. Among these antibodies, several (b12, 2G12, PG9, PG16 and VRC01) recognize conserved regions in GP120, whereas others (2F5, 4E10 and Z13e1) bind to juxtaposed linear epitopes within the GP41 MPER [10] [11] [12] [13] [14] [15] [16] .
The MPER is a highly conserved, tryptophan-rich, hydrophobic segment (residues 662-683) that is important for viral fusion 17 . This region lies at the base of the GP41 ectodomain, immediately proximal to the transmembrane segment of the protein. Structural analysis of the MPER from HIV-1 strain HXB2 suggests that the 2F5 and 4E10 epitopes are membrane encrypted within an L-shaped MPER on the membrane surface 18 . The MPER is configured into two helical parts with different membrane orientations: a tilted N-terminal segment (residues 664-672) and a nearly flat C-terminal helix (residues 675-683) connected to each other through a flexible hinge. This bipartite arrangement is well suited to mediate fusion-related conformational change. In line with this observation, biochemical and structural analyses suggest a possible interaction of 2F5 and 4E10 1 2 3 6 VOLUME 18 NUMBER 11 NOVEMBER 2011 nature structural & molecular biology a r t i c l e s with phospholipids 10, [19] [20] [21] [22] . Although in crystal structures there are no observed contacts between the tip of the unusually long heavy chain complementarity-determining region 3 (CDRH3) and the MPER peptide segment, CDRH3 is essential for neutralization by both 2F5 and 4E10 antibodies [23] [24] [25] [26] [27] . Elimination of the tip or of key hydrophobic CDRH3 residues abrogates the neutralizing activity of such 2F5 and 4E10 variants. As a consequence, it has been proposed that BNAbs to MPER associate initially with the viral membrane and subsequently capture the MPER in a two-step process 28 .
Extensive structural and biochemical information on the BNAb 2F5 and its sequential core epitope have guided the design of immunogens to elicit antibodies capable of inhibiting viral infection (ref. 29 and references therein). For example, epitope-engrafted scaffold immunogens configure the 2F5 core epitope (ELDKWA) in a manner precisely mimicking that of the 2F5-bound epitope as verified by X-ray crystallography, but scaffold-elicited antibodies such as 11F10 lack detectable neutralizing activity 30 . To understand this paradox, we conducted NMR, EPR and hydrogen-deuterium exchange (HX)-MS studies to assess the manner in which 2F5 binds to the MPER in a membrane environment. Our results show that the 2F5 paratope interacts extensively with the MPER segment and surrounding lipid in addition to the core epitope. Moreover, 2F5 induces substantial conformational changes in the hinge and N-terminal helical segment in a process that fosters the extraction of lipid-buried core residues and is dependent on the CDRH3 loop, whose lipid interaction per se is negligible in the absence of MPER binding. The rigidification of CDRH3 by an internal hydrogen bond network and a proline cluster in conjunction with hydrophobic residues at its tip allow the antibody to function as an extraction scoop. In addition to explaining why recognition of the core 2F5 epitope is insufficient in itself to mediate viral neutralization, our findings suggest that antibody can function as an atomic tool to mediate structural rearrangement. These findings extend the concept of antibody motion from that required to recognize a single state (that is, an induced fit) to that required to recognize two states (a membrane-embedded epitope and an extracted epitope). These data offer new insights for MPERdirected BNAb generation.
RESULTS

The 2F5 CDRH3 tip affects binding to membrane-embedded MPER
To investigate why an antibody with high affinity for target epitope recognition lacks functional antiviral activity, the binding mode of the non-neutralizing mAb 11F10, was compared to that of the BNAb 2F5. Consistent with structural studies, binding of 11F10 and 2F5 to an MPER peptide in the absence of lipid was comparable, as measured by surface plasmon resonance SPR assay (Fig. 1a) . Unexpectedly, 11F10 was incapable of interacting with the MPER when the peptide was arrayed on liposomes (Fig. 1b) . The substantial length of the 2F5 CDRH3 loop (22 residues) and its hydrophobic character (Fig. 1c) are thought to be important for mediating membrane interactions and 2F5 activity. Notably, 11F10 lacks these characteristics. Furthermore, double serine substitution in 2F5 at residues Leu100 A and Phe100 B of CDRH3 (2F5 L100 A S F100 B S) completely abrogate neutralizing activity, whereas the I100 F S and F100 B S single substitutions reduce potency by approximately two orders of magnitude relative to wild-type (WT) 2F5 in half-maximum inhibitory concentration (IC 50 ) viral-neutralization assays 26 . Although the affinity of the 2F5 L100 A S F100 B S mutant for the MPER peptide in the absence of lipid is not affected by the CDRH3 tip mutations (Fig. 1a) , consistent with previous findings 26 , the binding of 2F5 L100 A S F100 B S to the MPER segment is substantially reduced when configured on an HIV virion-mimic membrane surface (Fig. 1b) . As shown in Figure 1d and representative sensorgrams (see Supplementary Fig. 1 ), the binding equilibrium dissociation constant (K d ) that was observed for 2F5 L100 A S F100 B S (476 nM) was two orders of magnitude lower than that observed for WT 2F5 (3.1 nM). 2F5 I100 F S bound to the MPER segment less well than WT 2F5, with a K d of 28 nM, and 2F5 F100 B S manifested a decrease in K d to 97 nM.
Concurrent protection of 2F5 CDRH3 and L2 from HX
Despite the absence of contact between CDRH3 and the MPER peptide in a crystal structure (Fig. 1c) , the apex of CDRH3 may have an indirect but key functional role in mediating 2F5 binding to its core epitope. To examine this possibility, we used HX-MS to assess conformational changes 31 . After solvent deuterons were exchanged with backbone amide hydrogens for various time periods (15 s to 4 h) at rates dependent on hydrogen bonding and solvent accessibility, the quenched protein was digested with pepsin. Deuterium incorporation into each pepsin fragment was analyzed by electrospray MS 32 19 . Note that in the long CDRH3 loop, residues between 100 and 101 are numbered with appended letters (100, 100 A , 100 B and so on) by Kabat numbering. Heavy and light chains of 2F5 are indicated by orange and green, respectively. (d) SPR binding constants of WT 2F5 and mutant 2F5 variants binding to MPER segments on the surface of a DOPC-DOPG membrane linked to an L1 chip. Under our experimental conditions, no inverse correlation was seen between dissociation rate and contact time 21 (ranging from 30 s to 15 min) (see Supplementary Fig. 1b,c) , so binding data were fit to a 1:1 Langmuir model. a r t i c l e s carried out for the Fab of 2F5 F100 B S and 2F5 I100 F S, and data were compared. As a control, WT 2F5 Fab exchange was also measured in liposomes lacking the MPER peptide.
For most of peptides derived from the WT and mutant 2F5 Fab regions, there was little change in exchange following binding to MPER embedded in liposomes (Fig. 2b , top row, and Supplementary Figs. 3-5) . Likewise, exchange into the several CDR regions that contact the MPER in the crystal structure (for example, H1 and H2) was not affected differentially by the MPER being in solution or embedded in liposomes. Although light chain CDR-3 (CDRL3) also interacts with the MPER, no peptides covering CDRL3 could be located in the HX-MS experiments (see Supplementary  Fig. 2 ). However, there were reproducible differences in exchange for CDRH3 and CDRL2 of WT 2F5 Fab (Fig. 2b, left column) . The observed differences were well outside the error of deuterium-level determination (±0.25 Da). In these regions, the amount of deuterium incorporated into 2F5 was lowest in the presence of MPER embedded in liposomes, indicating that 2F5 is protected from exchange as a result of binding to MPER in the liposome.
Hydrogen exchange into the 2F5 F100 B S and 2F5 I100 F S Fab regions was compared to exchange into WT 2F5 Fab (Fig. 2b) . Exchange into each of the mutant Fab regions was not markedly altered in the absence of MPER, but obvious differences were found between WT and mutant Fab regions, when bound to MPER with and without lipid. For example, protection from exchange in CDRH3 and CDRL2 as a result of binding MPER in solution was reduced in both mutants relative to WT 2F5. The shape of the deuterium incorporation lines was also different between WT and mutants, in that MPER-bound mutant 2F5 became deuterated faster than WT 2F5. The raw mass spectra indicated that these changes were the result of redistribution of the population of multiple conformations.
A single 2F5 CDRH3 conformation with lipid-embedded MPER
In addition to protection from exchange, when 2F5 bound to the MPER in solution, the mass spectra indicated that the antibody adopted multiple conformers, in contrast to a single conformational population found for unligated 2F5. The regions where multiple conformational forms exist cover the C-terminal half (residues Phe100 B -Asp101) of CDRH3 and the N-terminal portion (residues 46-49) of CDRL2 were identified by unique isotopic distributions that are characteristic of multiple peptide conformations. An example of the spectra is shown in Figure 2c for CDRH3 (see also Fig. 3 for spectra of L2). Multiple populations distinguished themselves in these experiments by the appearance of bimodal isotope patterns. These patterns may be due to EX1 kinetics 33, 34 : one population represents a more exposed form of the protein, hence incorporating more deuterium to yield a higher mass (Fig. 2c , blue lines), whereas the other population is more protected, with less deuterium incorporated and a lower mass therefore (Fig. 2c, red lines) . These populations interconvert owing to protein 'breathing' or dynamics, but because the deuterium-labeling reaction is unidirectional (~95% (v/v) D 2 O solution), all molecular species eventually reach the higher mass (that is, the more deuterated form), and the rate of conversion between the two forms correlates with the change in the population distribution. A less protected form was found for CDRH3 of unbound 2F5 (2F5 alone), whereas multiple populations were found for 2F5 bound to soluble MPER (+ MPER only). This suggested that MPER binding slowed the 2F5 protein dynamics so that more time was required to reach the upper distribution. The 10-min time point is shown in Figures 2 and 3 for purposes of illustration, but the distributions were characterized for all time points. In the presence of lipid (+ MPER in lipid), there was only one protected form, as evidenced by the single-isotope distribution at lower mass ( Fig. 2c) and the decreased amount of exchange found in the incorporation graphs (Fig. 2b , triangle symbols in the WT Fab column). Therefore, MPER embedded in liposomes had the greatest ability to prevent protein breathing and dynamics in the WT 2F5 Fab, presumably owing to the influence of the lipids in altering the motions in the Fab, particularly in CDRH3 and, to a lesser extent, in CDRL2.
In contrast to the WT 2F5 Fab, in the CDRH3 and CDRL2 regions of the 2F5 F100 B S and 2F5 I100 F S Fab peptides there was no bimodal pattern after 10 min of labeling. Instead, an unprotected population resembling the unbound protein was observed (Fig. 3) . There was a bimodal pattern earlier in the time course of exchange, but the conversion rate between the protected and unprotected forms was much faster for the mutants than for WT 2F5, which is also shown by the rapid increase in the relative deuterium levels in the kinetic analysis (Fig. 2b) . Maximal deuteration was reached much more quickly in the mutants than in WT 2F5, as seen by comparing the line shapes of incorporation into CDRH3 and CDRL2 for 2F5 bound to MPER a r t i c l e s in liposomes (Fig. 2b, triangles) . By the 10-min time point shown in Figure 2c , both mutants were heavily deuterated, without the protection that was occurring for WT 2F5. Thus, mutation at the tip of the CDRH3 loop accelerates deuteration and dynamic conversion between conformations, consistent with a destabilized structure and/or the loss of a strong interaction that otherwise mediates solvent occlusion. Whereas the WT 2F5 Fab was stabilized by the MPER-lipid environment, this was not the case for the mutants. It was perhaps surprising to observe changes in CDRL2 when WT 2F5 Fab was bound to MPER in liposomes, considering that CDRL2 is at a distance from the MPER core epitope in the crystal structure. Nevertheless, the HX-MS data clearly indicated that CDRL2 was affected by interactions between 2F5 and MPER in liposomes, primarily only in WT 2F5 (Fig. 3b) . Two overlapping peptides in the HX-MS experiments (light chain residues 46-53 and 48-54) allowed us to conclude that the region of CDRL2 that was most involved in this effect was between residues 46 and 49, because the raw spectra of the shorter peptide (residues 48-54) did not have the bimodal kinetic signature observed in CDRL2 residues 46-53 and CDRH3 residues 100 B -100 N (as shown in Fig. 3) . The hydrophobic segment of CDRL2 ( 46 LLIY 49 ) is not surfaced exposed and, hence, is not anticipated to interact with membrane or contribute energetically to peptide binding, in contrast to CDRH3 (ref. 26 ). In the crystal structure, residues 46-50 of CDRL2 are directly across from the C-terminal half of CDRH3, the same region that had altered deuterium exchange on binding MPER in liposomes (Fig. 2a,b) . One hydrogen bond is observed between CDRL2 D50 and CDRH3 N100 L . Therefore, conformational change in CDRH3 may strengthen the association of CDRH3 with CDRL2 through additional hydrogen bonds or other contacts on productive interaction of WT 2F5 with MPER in liposomes, affording protection from deuterium exchange for both of these regions. This interaction is lost in both 2F5 single mutants, F100 B S and I100 F S.
MPER structural change upon 2F5 Fab interaction
We carried out a structural investigation of the WT 2F5 interaction with the MPER in dodecylphosphocholine (DPC) micelles using NMR spectroscopy. The fingerprint 2D 15 N-TROSY (transverse-relaxation optimized spectroscopy)-HSQC (heteronuclear single quantum coherence) spectrum of 15 N-13 C-2 D-labeled MPER peptide in the presence of unlabeled 2F5 Fab fragments showed large chemical-shift changes in the backbone amide peaks from a number of MPER residues ( Fig. 4a and Supplementary Fig. 6 ). MPER residues ranging from Leu660 to Phe673 were affected by 2F5 binding, with the most marked changes occurring for residues Lys665, Trp666 and Ala667 (numbering according to the HIV str. HXB2 peptide). These findings indicated that conformational changes in MPER subsequent to 2F5 binding extended well beyond the core epitope to include the central hinge region of MPER and possibly Thr676. Conversely, residues C-terminal to Thr676 were less perturbed, suggesting that the conformation of the C-terminal helix of MPER remained largely unchanged 35 . Secondary structures predicted from the 13 C chemical-shift values of MPER bound to 2F5 implied that there were marked conformational changes to the N-terminal region (Fig. 4b) . The N-terminal residues LLELD adopted an extended conformation when in contact with the antibody, and the helical conformation of the MPER N-terminal helix, including the core epitope, and of residues C-terminal to the 2F5-binding pocket had been disrupted.
To map the 2F5-bound MPER residues that are in close contact with the Fab, we acquired cross-saturation transfer 15 N-TROSY-HSQC spectra 36 using the same sample. The aliphatic-proton spectral region from the 2F5 Fab was irradiated and the saturation signals transferred to the amide peaks of the MPER through intermolecular NOE when residues of the MPER were close in space to the 2F5 surface. In this way, MPER residues nearby the 2F5 Fab were identified. Figure 4c shows the relative amount of signal reduction as a result of cross-saturation transferred from the 2F5 to the Fab-bound MPER residues. The most affected residues were in the core epitope region, but close contacts between the antibody and MPER extended C-terminally to include the MPER central hinge region. The region of intermolecular contact appeared to be between Glu662 and Phe673, a region that was similar in scope to that identified by the chemical-shift-perturbance data. The overall saturation levels were comparable to those of 4E10-bound MPER, but they were less than half those of Z13e1-bound MPER 35 , suggesting that 2F5 binding is similar to 4E10 binding and involves a small but deep epitope-binding pocket with a larger paratope contact area. By contrast, Z13e1 ligation is a rigid type of binding involving many MPER residues. In addition, cross-saturation data showed that the side chain amine groups of Trp670 and Trp672 were both in close contact with 2F5 (see Supplementary Fig. 6b) Figure 3 Mass spectra showing the loss of protection from deuterium exchange in 2F5 mutants. (a,b) The spectra for wild-type 2F5, 2F5 F100 B S and 2F5 I100 F S are shown for peptides from CDRH3 (a) and CRDL2 (b) after 10 min in deuterated buffer. For each protein, spectra were obtained for undeuterated 2F5, 2F5 alone, 2F5 in the presence of MPER in solution (+ MPER only) and 2F5 in the presence of liposomes containing embedded MPER (+ MPER in lipid). The data shown in a for WT 2F5 are the same as the data shown in Figure 2c . The bimodal, multiple-population phenomenon seen for WT 2F5 with MPER in solution were also observed at the other exchange time points (Fig. 2b). a r t i c l e s not observed, consistent with a rapid relaxation rate in the binding pocket. Overall, our data suggested that there were multiple contacts between 2F5 and MPER outside the ELDKWA core itself, including the region immediately flanking this core and up to the central hinge region (residues Phe673-Asn674).
MPER alanine scanning on binding of WT and mutant 2F5
To determine whether broader contacts with MPER residues C-terminal to the 2F5 core epitope were mediated by CDRH3 apex residues, binding of WT 2F5, 2F5 I100 F S and 2F5 F100 B S was compared through mutational-scanning analysis. Single-residue alanine substitutions of the MPER showed that the DKW sequence was essential for 2F5 binding to the MPER on the dioleoylphosphatidylcholin e-dioleoylphosphatidylglycerol (DOPC-DOPG) liposome (Fig. 5a) , consistent with previous results carried out in solution 19, 37, 38 . In contrast to binding of WT 2F5, the binding of 2F5 I100 F S and 2F5 F100 B S was affected by residues in addition to those core DKW residues, extending C-terminally as far as Trp678 (Fig. 5a,b ). An A667D mutation considerably diminished 2F5 I100 F S and 2F5 F100 B S binding (to ~4-6% that of WT 2F5), as did alanine replacement of membraneembedded Leu669, Trp670, Trp672, Phe673, Ile675 and Trp678, and of surface-exposed Asn671, Asn674,Thr676 and Asn677. Independent peptide analyses using a full-length MPER segment as well as a synthetic, C-terminally truncated MPER demonstrated that although WT 2F5 binding to the MPER was unaffected by residues C-terminal to the MPER N-terminal helix, truncation of the MPER C-terminal helix diminished 2F5 I100 F S and 2F5 F100 B S binding as a result of a faster dissociation rate (Fig. 5c,d ). The binding of 2F5 L100 A S F100 B S to the truncated MPER (Fig. 5d) was abrogated even at the tested antibody concentration of 100 µg ml −1 , although binding to full length MPER was detectable. In summary, the results suggested that the membrane interaction of CDRH3 tip fostered transient contact of 2F5 CDRH3 with residues in the C-terminal helix of MPER during initial or intermediate binding states.
The apex of the 2F5 CDRH3 loop mediates epitope extraction
To test the effect of mutations at the tip of the CDRH3 loop on MPER reorientation and to find any correlation with neutralization potency, membrane immersion depths of spin-labeled (R1) MPER reference residues L669R1 and W670R1 (ref. 35) were measured by EPR for 2F5 L100 A S, 2F5 F100 B S and 2F5 I100 F S. As shown in Figure 6a, a r t i c l e s of 2F5 Fab. We found that WT 2F5 Fab lifted the deeply buried residue L669R1 from the acyl chain region of lipid (depth >8 Å) out of the membrane surface and into the aqueous phase (depth < -5 Å), whereas W670R1 was moved from the lipid acyl chain region into the head group region. In contrast to WT 2F5 Fab, 2F5 F100 B S-induced immersion depth changes of L669R1 and W670R1 were attenuated at the head group and acyl chain regions, respectively (Fig. 6a) . The extraction of L669R1 appeared to be unaffected by 2F5 L100 A S and 2F5 I100 F S, but slightly reduced immersion depth changes were observed with W670R1 on 2F5 L100 A S and 2F5 I100 F S binding, compared to the changes induced by WT 2F5. The results suggest that mutations at different positions of the CDRH3 tip differentially affect the degree of reorientation of the N-terminal helix in the MPER. Of note, comparable changes in the EPR mobility spectra for L669R1 and W670R1 (see Supplementary Fig. 7 ) indicated the presence of similar MPER conformations at the antibody-binding interface for the WT and three mutant 2F5 Fabs.
To further test whether the attenuated extraction of residues in the N-terminal helix of MPER by the 2F5 variants affected antibody interaction with intact GP41 on native membranes, we carried out fluorescence-activated cell sorting (FACS) analysis of mAb binding to the HIV-1 GP160(ADA) transiently expressed on 293 T cells. As shown in Figure 6b , 36% of cells stained with WT 2F5, whereas the binding of 2F5 mutants was reduced: 26% of cells stained for 2F5 L100 A S, 20% for 2F5 I100 F S, 13% for 2F5 F100 B S and 3.9% for 2F5 L100 A S F100 B S. No detectable binding of 11F10 to GP41 was observed, even at the concentration of 0.2 mg ml −1 , consistent with the result shown in the SPR analysis (Fig. 1b) . These results suggested that the reorientation of membrane-embedded residues at the interface of the 2F5-binding pocket, mediated by CDRH3, was crucial both for binding affinity and, as previously shown 26 , for neutralization potency.
A model of 2F5 Fab binding to the MPER
On the basis of these NMR, EPR, HX-MS and functional results, we modeled the full-length MPER in complex with WT 2F5 Fab on a liposome surface. Details of the modeling are provided in the Online Methods. As shown in Figure 7a , the N-terminal segment of the MPER has been lifted vertically out from the membrane, and contacts between the hydrophobic CDRH3 loop and MPER juxtahinge residues probably contribute to complex stabilization. We propose that the CDRH3 loop acts like a scoop to extract the 2F5 core epitope residues into its binding pocket. As viewed from a 90° rotation of this MPER-2F5 Fab complex model, shown in Figure 7b , extraction causes 664 DKW 666 to fit into the deep binding pocket of 2F5, whereas 662 EL 663 and 669 LW 670 line the entrance and exit, respectively. The hydrophobic tip of the 2F5 CDRH3 loop is positioned in the membrane to be compatible with the HX-MS data. 19 , 4E10 (PDB 1TZG) 10 and Z13e1 (PDB 3FNO) 54 . Hydrophobic residues, green (including proline side chains); hydrogen bonds, dotted red lines.
a r t i c l e s
Notably, the 2F5 CDRH3 loop is rigidified by a cross-strand hydrogen bond network and the presence of three proline residues, and this rigidification facilitates extraction. Fig. 5 ), we suggest that 2F5 initially interacts with the solvent-exposed MPER residues Glu662, Leu663 and possibly Asp664, lifting up the MPER residues N-terminal to Asp664. As a result, the 2F5 CDRH3 loop comes into contact with the MPER at the peptide-lipid interface on the Trp672 side. The hydrophobic residues in the CDRH3 loop then insert deeper into the membrane to stabilize a β-sheet hairpin structure and, together with the proline-containing base of the loop, form a rigidified scoop. We suggest that this scoop lifts up the underside of the N-terminal helical segment of the MPER. That action involves a concerted movement in which the CDRH3 loop sweeps across the N-terminal front of the MPER, contacting Asp664, Lys665 and Trp666, and extracts Lys665 and Trp666 from the membrane into the 2F5 binding pocket, resulting in a tight complex. The tip of the CDRH3 loop with Phe100 B anchored into the membrane is crucial to stabilize the 2F5-MPER complex in this process. The single population of 2F5 CDRH3 and CDRL2 peptides that were protected from deuterium exchange in the presence of MPER embedded in liposome was probably an HX-MS correlate of this process. 2F5 F100 B S and, to a lesser extent, 2F5 L100 A S and2F5 I100 F S were less effective in excavating the buried core epitope residues, thereby resulting in partial extraction with prolonged extraction kinetics, as evidenced by slower on-rate constants (Fig. 1d) . We propose that those 2F5 mutations prevent the CDRH3 regions from interacting strongly with the MPER in lipid, resulting in the much faster appearance of highly deuterated species in HX-MS (Figs. 2 and 3) . This incomplete extraction may explain the observation that 2F5 100 F S and 2F5 F100 B S were sensitive to alanine mutations in the central hinge and the first turn of the C-terminal helix of MPER (Fig. 5) . Although there may be no contacts with these MPER residues in the final 2F5-MPER complex, during the intermediate stage of extraction, structural changes linked to the MPER alanine mutants and/or loss of direct side chain contacts may interfere with the extraction process mediated by these 2F5 CDRH3 mutants.
Functional consequences of the 2F5 mutations cannot be explained by loss of 'nonspecific' hydrophobic membrane interactions that are the single prerequisite for the subsequent MPER binding, as suggested previously 28 . Instead, 2F5 extraction of epitope residues on the MPER segment requires, in our view, three key regions: an initial MPER-capturing paratope adjacent to the core binding pocket (imparting specificity); a semirigid kinematic CDRH3 loop with flexible joints that can interact simultaneously with residues C-terminal to the binding pocket and with lipid membrane in an interaction that is necessary to extract core epitopes shielded by lipid head group or acyl chains (offering hydrophobic interaction energetics for lifting the MPER); and a tight paratope binding pocket for stable complex formation with the fully exposed core epitope (yielding a high affinity interaction).
A proline-based molecular switch: 2F5 CDRH3 extraction scoop From a survey of 516 antibody structures in the Protein Data Bank (PDB) database, only ~5% (26 of 516) possess rigid and long (≥14 residues) CDRH3 loops, including 2% (10 of 459) of non-HIVtargeting mAbs compared with 28% (16 of 57) of HIV-targeting mAbs. The CDRH3 loop of 2F5 is remarkable in its length (22 residues) and function, as noted above. We propose that the energy gained from favorable interactions of the CDRH3 tip with the membrane and MPER N-terminal segment can be efficiently transmitted through the rigid segments of the CDRH3 loop to facilitate extraction. Notably, the 2F5 CDRH3 loop contains three proline residues, a distinctive feature among known natural antibody structures in the PDB (aside from the tyrosine-sulfated 412D antibody to HIV-1 GP120 (ref. 39 ). In the case of 2F5, glycine residues N-terminal to two of the three prolines (Pro98 and Pro100 J ) may afford segmental flexibility in the structure around these maneuverable 'joints' . We envision that the cis-trans isomerization of these proline residues can act like a molecular switch 40, 41 to mediate dynamic robotic movement of the largely rigid CDRH3 loop for extraction (Fig. 7b,c) , locking it into a trans-proline state. The conformational change of the 2F5 CDRH3 loop on 2F5 binding to membrane-bound MPER, as observed by HX-MS, is consistent with this notion. Moreover, that transition may position the hydrophobic residues on one surface of the CDRH3 tip for membrane interaction in an energetically favorable manner 26 that can provide the energy source and trigger for this switching mechanism.
Implication for immunogen design
CDRH3 is the major determinant of antibody diversity and a key contributor to antigen affinity and specificity 42 . The selection bias of 2F5 progenitor B cells for a long CDRH3 loop may be driven by the context in which the MPER antigen is presented, being largely sterically occluded at the base of the glycosylated GP160 ectodomain in proximity to viral membrane 43 . A correlation between CDRH3 length and the nature of the antigen being recognized would set a precedent for such selection 44, 45 . Although some amino acids in the putative 2F5 germline antibody participated in interactions with certain core epitope residues, the germline-like antibody most closely corresponding to 2F5 lacks binding to soluble GP140 (refs. 46,47) . Somatic hypermutation may have occurred during prolonged antigen exposure, facilitating the generation of a higher-affinity antibody capable of neutralizing HIV-1 (ref. 48) . Crystal structures of other germline and affinity-matured antibodies have revealed structural plasticity of CDRH3, with an evolution of antibody affinity and specificity 49 . Hence, the high-affinity antigen-binding site of 2F5 may have evolved into an optimized binding site through conformational adaptation of the CDRH3 loop in proximity to the membrane. It is likely that one or more hydrophobic residue in the CDRH3 loop, including proline, coevolved for the extraction process and, as a result, enhanced antibody binding affinity by extending the 2F5 progenitor's binding-site contacts to buried residues. The weaker affinity of CDRH3 tip variants of 2F5 and the importance of additional contacts with the MPER C terminus for binding of these variants may be reminiscent of the evolving 2F5 progenitor during maturation.
A 2F5-like antibody with high affinity is achieved through conformational adaptation of the long CDRH3 loop in a membrane environment through extensive contact with MPER residues and membrane constituents. In turn, the geometry of MPER on the virus, along with the approach angle of the antibody relative to the viral surface, must be considered in immunogen design. Given the rarity of naturally elicited BNAbs to MPER in individuals infected with HIV-1 (ref. 50) , focusing the immune response on the MPER a r t i c l e s probably requires epitope-specific immunogens to avoid the immunodominance of other regions in GP41 and GP120. That said, presentation of the buried core epitope alone in an immunogen scaffold cannot generate a BNAb that first recognizes the membrane-exposed MPER elements before core extraction. Antigen-driven B cell selection of neutralizing antibody may thus require a successive, complementary immunization strategy.
Antibodies as tools to modify membrane-embedded structures
The multistep process beginning with the initial antibody encounter with surface-embedded MPER, followed by extraction and final ligation, resulting in structural rearrangement of the target, is not unique to 2F5. How the 4E10 CDRH3 function differs from that of 2F5 will be of interest to determine. The distinction in size, shape and number of prolines in the 2F5 and 4E10 CDRH3 scoops implies that important differences will be found in the extraction processes of these BNAbs and in the immunogens needed for their elicitation. Moreover, our findings have implications for exploiting antibodies to regulate key cellular-receptor functions through the induction of membranedependent reorganizations in macromolecular structure. Examples might include T cell receptors whose mechanosensor function is dependent on the physical force transmitted on ectodomain ligation 51 , growth receptors such as the epidermal growth factor receptor (EGFR) family members being dependent on asymmetrical dimerization of the kinase domain 52 , and plexins (receptors for semaphorins) inducing dimerization to control axonal guidance in the nervous system and cellular migration more generally 53 . Development of antibodies that can either interdict or mimic ligand-dependent events through membrane-directed structural rearrangements could create a new class of molecular robotic tools to regulate cellular processes. The HIV-1 GP41 example shows that membrane-active antibodies have potent biological effects that can be studied in explicit molecular terms.
METHODS
Methods and any associated references are available in the online version of the paper at http://www.nature.com/nsmb/.
Note: Supplementary information is available on the Nature Structural & Molecular Biology website.
